ATLASEli Lilly (LLY) earnings date: expected January 19–25
Eli Lilly (LLY) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 19–25. That is an estimate, not a confirmed date. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on LLY
| Last price | $1,410.99 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.1% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 6 reports |
| Dividend | $6.69 a year (0.47% yield) · next ex-date Nov 13, 2026 |
These figures come from the same calibrated model and valuation as the Eli Lilly stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after Eli Lilly reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountLLY earnings at a glance
| Next report | Not announced · expected around January 19–25 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 5 of 6 (83%) |
| Average EPS surprise | -7.7% |
| Average move around a report | ±5.8% (last 5) |
| Sector | Healthcare · Drug Manufacturers - General |
The expected window is an ATLAS estimate: it takes the typical gap between Eli Lilly’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Eli Lilly earnings history: last 6 reports
Eli Lilly last reported on Oct 29, 2026: EPS of $7.48 against an estimate of $5.38 (+39.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $5.38 | $7.48 | +39.0% | Beat | – |
| Aug 5, 2026 | $6.58 | $8.38 | +27.4% | Beat | +6.8% |
| Apr 30, 2026 | $6.79 | $8.55 | +25.9% | Beat | +13.2% |
| Feb 4, 2026 | $6.91 | $7.54 | +9.1% | Beat | +1.7% |
| Oct 30, 2025 | $5.89 | $7.02 | +19.2% | Beat | +6.1% |
| Sep 14, 2025 | $0.03 | -$0.02 | -166.7% | Miss | +1.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Eli Lilly latest earnings results
- Eli Lilly (LLY) Q3 2026 earnings results · reported Oct 29, 2026
Get the full ATLAS analysis for LLY
See the fair value, the probability range and the earnings history of Eli Lilly on its ATLAS page.
Eli Lilly (LLY) stock analysisPlans from €3.99 a month.
Eli Lilly earnings: frequently asked questions
When is Eli Lilly (LLY) next earnings date?
Eli Lilly has not announced its next report. Its last 4 reports came Oct 29, 2026, Aug 5, 2026, Apr 30, 2026, Feb 4, 2026, so ATLAS estimates the next one around January 19–25. This is an estimate based on that pattern, not a confirmed date.
How often does LLY beat earnings estimates?
Of its last 6 reports with a recorded result, Eli Lilly beat the EPS estimate 5 times; the average surprise was -7.7%. Past results do not predict the next one.
How much does LLY move around earnings?
Over its last 5 reports the stock moved an average of 5.8% (absolute, from the close before the report day to the close after it), and finished higher 5 of 5 times.
Did Eli Lilly beat earnings estimates last quarter?
Eli Lilly last reported on Oct 29, 2026: EPS of $7.48 against an estimate of $5.38 (+39.0% surprise), a beat.
How much does LLY usually move in a day?
On a normal trading day the ATLAS model puts LLY’s one-day range at about ±2.1%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer